This profile was last updated on .
Is this you? Claim your profile.
Solnavägen 1, Solna
Find other employees at this company (4,339)
(46 Total References)
Breaking News for 2001
"This is the basic information on how cells divide vital information for future treatment of most sorts of cancer," Karolinska Institute Professor and cancer expert Ulrik Ringborg told a news conference.
Ulrik Ringborg of the ...
Ulrik Ringborg of the Karolinska Institutet, the project's coordinating partner, remarked: "The EurocanPlatform has created a multidisciplinary environment to structure research collaboration between preclinical and clinical cancer research centres for translational research aimed at personalized cancer medicine.
There then followed the Stockholm ...
There then followed the Stockholm Declaration, led by Ulrik Ringborg at the Karolinska, which is a manifesto drawn up by 18 cancer centres to achieve such a platform.
"Following this, and recommendations from the ECCO
oncopolicy committee and the Organisation of European Cancer Institutes
(OECI), the European Commission
funded under FP7 a network of excellence, led by Ringborg
, to structure translational cancer research between cancer research centres in Europe, namely the Eurocan platform" (see www.eurocanplatform.eu).
Ringborg, director of Stockholm's Karolinska Cancer Centre, describes Celis as "a remarkable man", in both his scientific work and his capacity for networking.
Having worked alongside Celis in some big European projects, including the Eurocan platform, Ringborg
also singles out his "unusual capability to organise and convince people about both infrastructures and research strategies," and also his grasp of the need to find new types of collaboration and financial support to improve the innovative potential in cancer research.
Oncology and Hematology Editorial Board
Ulrik Ringborg - Professor, Cancer Center Karolinska, Karolinska University Hospital
Professor, Cancer Center Karolinska, Karolinska University Hospital
has authored 273 publications in international journals and books, with scientific focus on malignant melanoma.
Prof. Ringborg is a member of the Research Board and the Governing Body (Vice Chairman) of the Swedish Cancer Society.
He is a member of the Scientific Advisory Committee of EORTC and a member of the Steering Group of NOCI, EORTC.
He was President of the European Society of Skin Cancer Prevention (2002-2003) and Chairman of the Advisory Board for UV-protection, Swedish Radiation Protection Authority.
EAPM - Dublin Conference Programme
- Ulrik Ringborg
Prof. Ulrik Ringborg, Executive Committee Member, Eurocan Platform
Ulrik Ringborg is a Professor of Oncology, graduating from the Karolinska Institute in 1992.
Since 1994 he has held the position of Director of the Cancer Centre in Karolinska.
Professor Ringborg completed his PhD thesis in basic biology in 1971, graduated and received his State registration as a medical practitioner in 1972.
In 1974 he joined the Department of General Oncology at Radiumhemmet and became an Associate Professor of General Oncology in 1978.
He qualified as a specialist in oncology in 1979.
In 1992 he was appointed to Senior Consultant.
Subsequently, he was appointed Professor of Oncology at the Karolinska Institute and Head of the Department of Oncology of Karolinska Hospital.
In 1993 he
became the Prefect at the Institute of Oncology-Pathology and held this position for three years.
From 1996 until 2003, Ulrik was a Member of the Executive Group of the Karolinska Hospital and the following years, 2003- 2004, served as the Head of the Oncologic Clinic at the new Karolinska University Hospital.
He is a member of several committees, including Member of the Research Board and the Governing Body of the Stockholm Cancer Society, Member of the Research Board and the Governing Body of the King Gustaf V Jubilee Fund and of the Research Board and the Governing Body (Vice Chairman) of the Swedish Cancer Society.
Moreover, he was a Member of the Scientific Advisory Committee of EORTC and, at present, is a member of the Steering Group of NOCI within the EORTC.
He served as a Member of the Nobel Assembly from 1993 until 2008.
He was the President of European Society of Skin Cancer Prevention (2002-2003) and the President of the Organization of European Cancer Institutes (2005-2008).
Professor Ringborg has held numerous prestigious positions including Chairman of the Swedish Melanoma Study Group from 1976 to 2003, Chairman of the Investigation of Radiotherapy of Cancer from 2000 to 2003 at the Swedish Council on Technology Assessment in Healthcare and Chairman of the Development of National Guidelines for Cancer within the National Board of Health and Welfare (1998-2001).
was awarded Honorary Membership of the Radiological Society of North America and the Hungarian Cancer Society
The author of around 280 international publications, his
scientific focus is on malignant melanoma.